Navigation Links
How much is the world spending on neglected disease research and development?
Date:2/4/2009

The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine, finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseasesHIV/AIDS, TB, and malariareceiving nearly 80% of the total.

However, the survey finds that many neglected diseases, responsible for killing millions of people in developing countries, are significantly underfunded.

Researchers from The George Institute report that while HIV/AIDS, TB and malaria collectively received the majority of R&D funding, other diseases and disease categories each received less than 5% of global funding.

Sleeping sickness, leishmaniasis and Chagas disease collectively received only 4.9% of total global funding; the diarrhoeal illnesses surveyed collectively received 4.5% of global funding; the helminth (worm) infections received 2%; and bacterial pneumonia and meningitis received only 1.3%. Five diseases - leprosy, Buruli ulcer, trachoma, rheumatic fever, and typhoid and paratyphoid fever each received less than $10 million or 0.4% of total global investment. For many of these diseases, funding was not enough to create even one new product.

The need for R&D to develop new drugs and vaccines for preventing and treating neglected tropical infections in developing countries is widely accepted. For example, the creation of a vaccine for HIV/AIDS, more effective tools to diagnose TB, and better drug treatments for leishmaniasis and sleeping sickness would greatly improve health in the developing world. However, there has until now been an "information gap" for funders wishing to invest in this area.

In the new survey by Dr Mary Moran (The George Institute for International Health, Sydney, Australia) and colleagues, commissioned by the Bill and Melinda Gates Foundation, the researchers set out to fill this information gap. While specific R&D investment data were previous
'/>"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Worlds First Website for Patients to Share Diagnostic-Quality Medical Images
2. Rotary Members Worldwide Prepare For Mass Immunization Campaigns In Polio-Endemic Countries
3. Wesley Mosley Selected to Participate in Global Youth Activation Summit During the 2009 Special Olympics World Winter Games
4. A World First in Minimally Invasive Robotic Surgery Promises a More Cost-Effective, Patiently Friendly Future
5. The Only 100% Biologically Pure Lycopene Cream in the World
6. World-renowned Instructor of the Healing Practice of Qigong to Teach in Los Angeles Mar. 7 & 8
7. Z Trim to Be Distributed to Meat and Poultry Industries by World Technology Ingredients
8. In the World of Germs, Man Bites Dog
9. Nano World Headquarters Positioned to Boost U.S. Economy
10. This February Discovery en Espanol Delves Into The Subconscious World of Attraction in Science of Sex Appeal
11. Worlds First Medical Identification Franchise Launches Nationally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... ORLEANSA drug that has become a mainstay of ... re-establishing the immune system of patients who have ... donors, according to early clinical trial results to ... investigators at the American Society of Hematology,s (ASH) ... Ernest N. Morial Convention Center, Room 243-245, 5:45 ...
(Date:12/6/2009)... 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... the pivotal Phase 2b 003-A1 study, known as ... in heavily pre-treated relapsed and refractory multiple myeloma ... ASH/ASCO Joint Symposium at the 51st annual meeting ... New Orleans. Enrollment in this trial is complete ...
(Date:12/6/2009)... the community, in cooperation with the Greater VA Healthcare System in ... year,s attendance is expected to soar to more than 5,000 veterans, ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members of ... West Los Angeles, will once again create a holiday party. This ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
(Date:12/5/2009)... their cleaning processes. The technology available to the lab allows it ... customers relating to cleaning parts, process development, and verification. , ... ... a Jackson, MI-based company, is home to an advanced technology center ...
Breaking Medicine News(10 mins):Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... Executive Director of the Iowa Chronic Care Consortium, is ... ... NORTHFIELD, Ill., March 6 Today Pharos Innovations, a,remote ... conditions, announced the first recipient of a new award ...
... Researchers have for the first time cleared an important ... Neutropenia (SCN), a deadly disease characterized by a deficiency ... cell important to fighting infection and disease. A research ... in the March 14 Immunity the first evidence of ...
... LDG ) today reported preliminary total retail drug,store sales of $379 million for the four-week period ended ... (Dollars in millions) ... ... ...
... March 6, 2008 A study released ... Alto Healthcare System in California shows that non-polypoid colorectal ... Americans than previously thought and may have a greater ... more commonly diagnosed colorectal polyp. The study appears in ...
... PITTSBURGH, March 6 Statement from Chuck,Mohan, ... Mitochondrial Disease,Foundation on reports of possible links ... are no scientific studies documenting that childhood,vaccinations ... is very,little scientific research in this area. ...
... March 6 SpectraCell Laboratories, Inc.,announced that the ... to its scientific,staff as Manager of Research & ... from the University of Texas,M.D. Anderson Cancer Center. ... of cellular and molecular biology research, as well ...
Other Medicine News:Health News:Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research 2Health News:Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research 3Health News:Function of molecular switch pinpointed in severe congenital neutropenia 2Health News:Function of molecular switch pinpointed in severe congenital neutropenia 3Health News:Longs Reports Preliminary February Retail Drug Store Sales 2Health News:Colonoscopy used to identify and remove flat colon lesions 2Health News:Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories 2
(Date:12/4/2009)... (NYSE: HSP ), a leading global specialty ... of its next-generation 50 mL and 100 mL VisIV(TM) ... offers a complete size range (50 mL to 1 ... launch of the 50 mL and 100 mL containers ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a ... chemical threats, announced today that the Company is ... of Valortim® in an inhalation anthrax model in ... data are being presented during an oral session ...
(Date:12/4/2009)... Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation ... and successful testing of a novel integrated light source ... optical engine design raises the bar on imaging speed ... source OCT light sources. This approach to optical ...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 1ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 2ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 1New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 2New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 4Sarnova Names Hank Struik Chief Executive Officer 48162 1Sarnova Names Hank Struik Chief Executive Officer 48162 2Sarnova Names Hank Struik Chief Executive Officer 48162 3
... The Matrix Perimeter utilizes Welch ... a significant breakthrough in visual field ... capabilities, tools to characterize glaucoma and ... Humphrey FDT Perimeter, the Matrix doubles ...
... IMAGE1 is the first completely digital camera ... in the field of endoscopic camera systems. ... the first time, facilitates the fully digital ... quality using an A/D converter, as well ...
... been a standard requirement for ... during laser procedures, however, many ... that smoke plume generated from ... as smoke plume generated from ...
Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery...
Medicine Products: